These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 3888215

  • 1. Lack of strong association between residual human C-peptide secretion and islet cell antibodies, complement-dependent antibody-mediated cytotoxicity, and HLA antigens in newly diagnosed type I diabetics.
    Michaelis D, Rjasanowski I, Hehmke B, Kohnert KD, Hildmann W, Keilacker H, Richter KV.
    Biomed Biochim Acta; 1985; 44(1):99-106. PubMed ID: 3888215
    [No Abstract] [Full Text] [Related]

  • 2. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
    Hehmke B, Michaelis D, Hildmann W, Richter KV, Kohnert KD.
    Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
    [Abstract] [Full Text] [Related]

  • 3. Is there a relationship between islet cell surface antibodies and clinical, biochemical, hormonal, and immunogenetic parameters in newly diagnosed type I diabetics?
    Michaelis D, Rjasanowski I, Ratzmann KP, Strese J, Dietz H, Hildmann W.
    Acta Biol Med Ger; 1982 Feb; 41(12):1093-8. PubMed ID: 6765149
    [No Abstract] [Full Text] [Related]

  • 4. Persistence of anti-islet ADCC after manifestation of type-1 (insulin-dependent) diabetes.
    Köhler E, Knospe S, Besch W, Michaelis D, Rjasanowski I.
    Exp Clin Endocrinol; 1989 Feb; 94(3):357-62. PubMed ID: 2698355
    [Abstract] [Full Text] [Related]

  • 5. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
    Charles MA, Suzuki M, Waldeck N, Dodson LE, Slater L, Ong K, Kershnar A, Buckingham B, Golden M.
    J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M, Durinovic-Bello I, Ziegler AG.
    J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
    [Abstract] [Full Text] [Related]

  • 9. Validity of WHO criteria for classification of newly diagnosed diabetics.
    Michaelis D, Rjasanowski I, Hildmann W, Kohnert KD, Richter KV.
    Exp Clin Endocrinol; 1985 Feb; 85(1):61-9. PubMed ID: 3886412
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Complement-dependent cytotoxicity of monoclonal antibodies against islet cells.
    Witt S, Hehmke B, Dietz H, Ziegler B, Hildmann W, Ziegler M.
    Biomed Biochim Acta; 1985 Feb; 44(1):117-21. PubMed ID: 3888203
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes.
    Knip M, Kukko M, Kulmala P, Veijola R, Simell O, Akerblom HK, Ilonen J.
    Am J Med Genet; 2002 May 30; 115(1):48-54. PubMed ID: 12116176
    [Abstract] [Full Text] [Related]

  • 16. Antibody-dependent cell-mediated cytotoxicity of mononuclear cells against Langerhans islets of Wistar rats in normal man and in patients at diabetes risk.
    Köhler E, Knospe S, Woltanski G, Maciejewski R, Salzsieder C, Rjasanowski I, Strese J, Michaelis D.
    Biomed Biochim Acta; 1984 May 30; 43(5):627-33. PubMed ID: 6383366
    [Abstract] [Full Text] [Related]

  • 17. [Islet-cell antibodies and organ-specific antibodies in diabetic children and adolescents. Relationship with age, age at onset, duration of diabetes, residual insulin secretion and retinopathy (author's transl)].
    Dorchy H, Lemiere B, Toussaint D, Gausset P.
    Nouv Presse Med; 1981 Sep 26; 10(34):2795-8. PubMed ID: 7031599
    [Abstract] [Full Text] [Related]

  • 18. Correlation between complement-fixing islet-cell antibodies and the clinical onset of insulin-dependent diabetes.
    Volta U, Bonazzi C, Cacciari E, Salardi S, Baldoni A, Pisi E.
    Ann Med Interne (Paris); 1988 Sep 26; 139(2):143-4. PubMed ID: 3293500
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P, Külkey O, Luczay A, Bornemisza B, Illyés G, Halmos T, Baranyi E, Blatniczky L, Mészáros J, Kerényi Z, Geró L, Tamás G, Hosszúfalusi N, Horváth L, Madácsy L, Romics L.
    Orv Hetil; 1999 Nov 28; 140(48):2695-701. PubMed ID: 10645715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.